Skip to main content
OpenTrials

Clinical trial condition

Atopic Dermatitis

Explore clinical trials studying Atopic Dermatitis. Study availability and eligibility vary by location and protocol.

857 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Atopic Dermatitis trial results

Completed

A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

NCT06436183

Conditions
Atopic, Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Medical Dermatology Specialists, PC/US Dermatology Partners Phoenix, Arizona, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • First OC Dermatology Research, Inc. Fountain Valley, California, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
View all 35 locations
View Trial Details
Completed

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

NCT04033367

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Number :8400012 North Little Rock, Arkansas, United States
  • Investigational Site Number :8400002 Redwood City, California, United States
  • Investigational Site Number :8400001 Rolling Hills Estates, California, United States
  • Investigational Site Number :8400013 Colorado Springs, Colorado, United States
View all 42 locations
View Trial Details
Completed

Dupilumab in Japanese Patients With Atopic Dermatitis

NCT04678882

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Number : 3920011 Nagoya, Aichi-ken, Japan
  • Investigational Site Number : 3920014 Toyoake-shi, Aichi-ken, Japan
  • Investigational Site Number : 3920015 Fukutsu-shi, Fukuoka, Japan
  • Investigational Site Number : 3920001 Hiroshima, Japan
View all 19 locations
View Trial Details
Completed

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

NCT04992546

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Collaborative Neuroscience Research-Site Number:8400004 Long Beach, California, United States
  • California Allergy & Asthma Medical Group-Site Number:8400008 Los Angeles, California, United States
  • Florida International Research Center-Site Number:8400017 Miami, Florida, United States
  • Lenus Research & Medical Group-Site Number:8400006 Sweetwater, Florida, United States
View Trial Details
Completed

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

NCT05186805

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Dermavant Investigative Site Thousand Oaks, California, United States
  • Dermavant Investigative Site Centennial, Colorado, United States
  • Dermavant Investigative Site Coral Gables, Florida, United States
  • Dermavant Investigative Site Hialeah, Florida, United States
View Trial Details
Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

NCT05014568

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Dermavant Investigative Site Birmingham, Alabama, United States
  • Dermavant Investigative Site Phoenix, Arizona, United States
  • Dermavant Investigative Site Bryant, Arkansas, United States
  • Dermavant Investigative Site Beverly Hills, California, United States
View all 67 locations
View Trial Details
Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

NCT05032859

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Dermavant Investigative Site Birmingham, Alabama, United States
  • Dermavant Investigative Site Scottsdale, Arizona, United States
  • Dermavant Investigative Site Scottsdale, Arizona, United States
  • Dermavant Investigative Site Fort Smith, Arkansas, United States
View all 62 locations
View Trial Details

Related conditions